MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy.
Peeken JC, Asadpour R, Specht K, Chen EY, Klymenko O, Akinkuoroye V, Hippe DS, Spraker MB, Schaub SK, Dapper H, Knebel C, Mayr NA, Gersing AS, Woodruff HC, Lambin P, Nyflot MJ, Combs SE.
Peeken JC, et al. Among authors: dapper h.
Radiother Oncol. 2021 Nov;164:73-82. doi: 10.1016/j.radonc.2021.08.023. Epub 2021 Oct 4.
Radiother Oncol. 2021.
PMID: 34506832